1. Unit startpage
  2. Employees
  3. Bjørn Helge Haug
No picture, placeholder image
No picture, placeholder image
Førsteamanuensis Klinihkalaš medisiinna instituhtta bjorn.haug@uit.no

Bjørn Helge Haug

  • Cecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, Hugo Lagercrantz, Per Kogner, Thomas Ringstedt et al.:
    Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
    BMC Cancer 2016 DOI
  • Bjørn Helge Haug, Øyvind Hald, Peter Utnes, Sarah A Roth, Cecilie Løkke, Trond Flægstad et al.:
    Exosome-like extracellular vesicles from MYCN-amplified neuroblastoma cells contain oncogenic miRNAs
    Anticancer Research 2015 SAMMENDRAG / ARKIV
  • Jørn Remi Henriksen, Bjørn Helge Haug, Jochen Büchner, Ellen Tømte, Cecilie Løkke, Trond Flaegstad et al.:
    Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
    BMC Developmental Biology 2011 FULLTEKST / ARKIV / DOI
  • Jochen Buechner, Ellen Tømte, Bjørn Helge Haug, Jørn Remi Henriksen, Cecilie Løkke, Trond Flægstad et al.:
    Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
    British Journal of Cancer 2011 ARKIV / DOI
  • Bjørn Helge Haug, Jørn Remi Henriksen, Jochen Buechner, Dirk Geerts, Ellen Tømte, Per Kogner et al.:
    MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
    Carcinogenesis 2011 DOI
  • Jochen Büchner, Jørn Remi Henriksen, Bjørn Helge Haug, Ellen Tømte, Trond Flaegstad, Christer Einvik :
    Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells
    Differentiation 2011 DOI
  • Trond Flægstad, Bjørn Helge Haug, Jochen Buechner, Jørn Remi Henriksen, Per Kogner, Tommy Martinson et al.:
    MYCN-REGULATED MIRNA-92 INHIBITS SECRETION OF THE TUMOR SUPPRESSOR DICKKOPF-3 (DKK3) IN NEUROBLASTOMA
    Pediatric Blood & Cancer 2011
  • Jørn Remi Henriksen, Bjørn Helge Haug, Jochen Büchner, cecilie LØkke, Trond Flaegstad, christer Einvik :
    Conditional MYCN knockdown using shRNAs encoded by retrovirus vectors
    2010
  • Bjørn Helge Haug, Jørn Remi Henriksen, Baldur Sveinbjørnsson, Trond Flaegstad, christer Einvik :
    The tumour suppressor DKK3 is a direct target of MYCN regulated miRNAs
    2010
  • Jørn Remi Henriksen, Jochen Büchner, Bjørn Helge Haug, christer Einvik, Trond Flaegstad :
    Combination of RA Treatment and MYCN-knockdown in MYCN Amplified Neuroblastoma
    2010
  • Trond Flaegstad, Jochen Büchner, Jørn Remi Henriksen, cecilie LØkke, Ellen Tømte, Bjørn Helge Haug et al.:
    MYCN PARTICIPATES IN A REGULATORY MIRNA NETWORK IN MYCN-AMPLIFIED NEUROBLASTOMA
    Pediatric Blood & Cancer 2009

    • The 50 latest publications is shown on this page. See all publications in Cristin here →